FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to a hemostatic agent able to stop bleedings and to glue tissues. Proposed glue represents an aqueous solution containing 50-200 g of sodium alginate, 150-200 g of feracryl and distilled water, up to 1 l. Invention provides enhancing the hemostatic activity. Time for film formation in contact of agent with blood and tissues is 30 s.
EFFECT: improved properties of glue.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HEMOSTATIC GLUE | 2004 |
|
RU2256448C1 |
| HEMOSTATIC GLUE | 2004 |
|
RU2262937C1 |
| HEMOSTATIC GLUE | 2004 |
|
RU2270015C1 |
| HEMOSTATIC GLUE | 2004 |
|
RU2257901C1 |
| HAEMOSTATIC AGENT | 2004 |
|
RU2275201C2 |
| HAEMOSTATIC GLUE POWDER | 2005 |
|
RU2304440C2 |
| INCOMPLETE SODIUM SALT OF POLYACRYLIC ACID, METHOD OF ITS OBTAINING AND BASED ON IT MEDICATION, POSSESSING HEMOSTATIC ACTION IN EXTERNAL APPLICATION | 2008 |
|
RU2428990C2 |
| POLYACRYLIC ACID INCOMPLETE ZINC SALT, METHOD FOR ITS PREPARING AND AGENT BASED ON THEREOF POSSESSING ANTISEPTIC, HEMOSTATIC AND WOUND-HEALING EFFECT IN EXTERNAL USING | 2006 |
|
RU2314815C1 |
| EFFICIENT HEMOSTATIC MEDICATION BASED ON LITHIUM AND DOUBLE LITHIUM-ZINC SALT OF POLYACRYLIC ACID | 2008 |
|
RU2424813C2 |
| INCOMPLETE CESIUM SALT OF POLYACRYLIC ACID, METHOD OF ITS OBTAINING AND BASED ON IT MEDICATION, POSSESSING HEMOSTATIC ACTION IN EXTERNAL APPLICATION | 2008 |
|
RU2428989C2 |
Authors
Dates
2006-02-20—Published
2004-03-09—Filed